Massachusetts General Hospital
- Advisory Board: Abbott Laboratories; Eli Lilly and Company; McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Novartis Pharmaceutical Corporation; Shire Pharmaceuticals Inc.
- Consultant: Abbott Laboratories; AstraZeneca LP; Eli Lilly and Company; McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Merck & Co., Inc.; National Institutes of Health; Novartis Pharmaceutical Corporation; Shire Pharmaceuticals Inc.
- Grant Support: Abbott Laboratories; Eli Lilly and Company; McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Merck & Co., Inc.; National Institutes of Health (National Institute on Drug Abuse); Shire Pharmaceuticals Inc.
- Honorarium for participation in this meeting: American Academy of Child & Adolescent Psychiatry
- Past Speaker's Bureau: Eli Lilly and Company; McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Novartis Pharmaceutical Corporation; Shire Pharmaceuticals Inc.
- Royalties: Guilford Press
- Travel Support to attend this meeting: American Academy of Child & Adolescent Psychiatry